The independent source for health policy research, polling, and news.
601-620 of 113,253 results
As Haitian temporary protected status (TPS) ended this week, so did the employment authorization for those immigrants. Healthcare leaders and state officials express concern over the loss of vital healthcare industry workers, Central Florida Public Media and the CT Mirror reported.
News outlets cover various aspects of the outbreaks, including the difficulty of tracing the parasite, public health missteps, and signs of improvement in Michigan. Also: RSV, Ebola, babesiosis, and more.
CMS Administrator Dr. Mehmet Oz said Tuesday in a post on social media that the subsidies had been ended because the insurers no longer needed them, The New York Times reported.
Today's early morning highlights from the major news organizations.
Opinion writers tackle these public health topics.
Doctors United spokesperson Kayla Blado said the unionization effort is "in early stages" and is in the process of gathering representation cards from physicians who attest, "I want SEIU Doctors United to represent me," MedPage Today reported.
This week, the Springfield Planned Parenthood location again began offering medication abortion after courts ruled several of the state's abortion regulations were unconstitutional. Also in the news: Weill Cornell Medicine has reached a voluntary compliance agreement with the federal government.
Centanafadine is a once-daily, extended-release capsule and the first and only norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI) approved for the treatment of ADHD, said Otsuka, which developed the drug and will market it under the name Simtriyo. Also in the news: oral antibiotics for kids with pneumonia; AI to help with gene editing; and more.
The AP reported on the National Survey on Drug Use and Health, which showed hopeful trends related to adolescents' substance use, depressive episodes, suicidal thoughts, and more. Also: protections for neurodivergent kids, the impact of cellphones on kids' reading comprehension, how financial stress can damage the brain, and more.
Former NIH scientist Anthony Fauci wrote about President Donald Trump's insistence to put a positive spin on the coronavirus outbreak that began in 2020 and his own challenges in handling the public health crisis. He is set to testify Wednesday on Capitol Hill, where Sen. Rand Paul (R-Ky.) is expected to grill him about the origins of the outbreak.
Rep. Robert Garcia (D-Calif.) has requested documents from Taylor Farms, the White House, the FDA, and the CDC that could shed light on reports that company executives and government officials sought "to distance the company from the outbreak and cast doubt on the officials’ conclusion," The Hill reported.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health issues.
And the death toll is likely higher, experts told The Washington Post, because of the United States’ slow and sometimes haphazard approach to assessing deaths from extreme temperatures.
Politico reports that Students for Life of America spent two years analyzing water samples in different American cities. They have released a report that purports to show “significant levels of mifepristone” in the waterways of Austin, Texas; Blacksburg, Virginia; and Carbondale, Illinois. Several environmental experts told Politico that there are flaws in the study’s methodology and its conclusions are “misleading."
Last week, OpenAI released Health in ChatGPT, allowing users to upload their medical records and connect them to Apple Health.
Demand for food-is-medicine programs is rising as the Supplemental Nutrition Assistance Program, or SNAP, prepares for an estimated $186 billion in federal funding cuts over the next decade, Modern Healthcare reports. Other news on healthcare costs is on a rise in those who are uninsured, the 340B program, and more.
The FDA’s Pharmacy Compounding Advisory Committee approved the peptides epitalon and semax for compounding, but not everyone thinks it's a good idea. Experts say this move might lead people to think the FDA has thoroughly evaluated these compounds, NBC News reported, when it has not. “At stake is literally the future of the FDA drug approval process,” one doctor said.
A little more than halfway through the year, the United States has already confirmed more cases — 2,318 — than it had in 2025. Public health experts say a full-throated vaccination push at the national level would stem the tide in cases but acknowledge that seems unlikely under the current administration. Plus, the latest on rising cyclosporiasis cases.
Today's early morning highlights from the major news organizations.
© 2026 KFF